Large language models for risk-of-bias assessment in randomised clinical trials — a comparative validation study.
AI models now assist systematic reviewers in evaluating study quality, potentially accelerating evidence synthesis across medicine and broadening access to quality appraisals.
This validation study in EBioMedicine benchmarks LLMs against human expert reviewers for risk-of-bias assessment in randomized clinical trials, finding that certain models achieve agreement rates sufficient to augment or partially automate systematic review workflows. The findings have broad implications for AI-assisted evidence synthesis across clinical disciplines.
What the study was
- Study design
- Comparative validation study
- Population
- LLM systems vs. human reviewers for RCT risk-of-bias assessment
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- EBioMedicine
Why it surfaced
Validation study design in EBioMedicine with direct clinical decision support implications; LLMs for evidence synthesis is actively implemented in clinical informatics workflows.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.